Acute deep vein thrombosis

Vishal Kapur, Sagar Goyal

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Acute deep venous thrombosis (DVT) is a life-threatening condition that can have serious potential consequences. This chapter overviews the comprehensive management of patients with acute DVT. Lower-extremity DVT and pulmonary embolism (PE) are two manifestations of venous thromboembolism (VTE). When VTE is diagnosed, immediate initiation of anticoagulant therapy is imperative. There are three phases of VTE treatment: the initial, long-term, and extended periods. Over the past decade, direct oral anticoagulants, including the direct thrombin inhibitor dabigatran and the factor Xa inhibitors rivaroxaban, apixaban, and edoxaban, have been studied and are now recommended by the 2016 American College of Chest Physicians and the 2014 and 2017 European Society of Cardiology guidelines for both DVT and PE. Extended treatment for long-term prevention of recurrent VTE is indicated for patients with unprovoked VTE, unless bleeding risk is high.

Original languageEnglish
Title of host publicationEndovascular Interventions
Subtitle of host publicationA Step-by-Step Approach
Publisherwiley
Pages196-206
Number of pages11
ISBN (Electronic)9781119467779
ISBN (Print)9781119467861
DOIs
StatePublished - 14 Jul 2023

Keywords

  • Acute deep venous thrombosis
  • Anticoagulant therapy
  • Bleeding risk
  • Direct oral anticoagulants
  • Extended treatment
  • Pulmonary embolism
  • Venous thromboembolism

Fingerprint

Dive into the research topics of 'Acute deep vein thrombosis'. Together they form a unique fingerprint.

Cite this